3-130379501-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001278298.2(COL6A5):āc.751T>Gā(p.Leu251Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000709 in 1,551,360 control chromosomes in the GnomAD database, with no homozygous occurrence. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000039 ( 0 hom., cov: 32)
Exomes š: 0.0000036 ( 0 hom. )
Consequence
COL6A5
NM_001278298.2 missense
NM_001278298.2 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 1.27
Genes affected
COL6A5 (HGNC:26674): (collagen type VI alpha 5 chain) This gene encodes a member of the collagen superfamily of proteins. The encoded protein contains multiple von Willebrand factor A-like domains and may interact with the alpha 1 and alpha 2 chains of collagen VI to form the complete collagen VI trimer. Polymorphisms in this gene may be linked to dermal phenotypes, such as eczema. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A5 | NM_001278298.2 | c.751T>G | p.Leu251Val | missense_variant | 4/41 | ENST00000373157.9 | NP_001265227.1 | |
COL6A5 | NM_153264.7 | c.751T>G | p.Leu251Val | missense_variant | 4/40 | NP_694996.5 | ||
COL6A5 | NR_022012.3 | n.1089T>G | non_coding_transcript_exon_variant | 4/42 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A5 | ENST00000373157.9 | c.751T>G | p.Leu251Val | missense_variant | 4/41 | 2 | NM_001278298.2 | ENSP00000362250 | P2 | |
COL6A5 | ENST00000312481.11 | c.751T>G | p.Leu251Val | missense_variant, NMD_transcript_variant | 4/42 | 1 | ENSP00000309762 | |||
COL6A5 | ENST00000512836.6 | c.751T>G | p.Leu251Val | missense_variant | 4/40 | 2 | ENSP00000422898 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152086Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000650 AC: 1AN: 153764Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81586
GnomAD3 exomes
AF:
AC:
1
AN:
153764
Hom.:
AF XY:
AC XY:
0
AN XY:
81586
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000357 AC: 5AN: 1399156Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 690096
GnomAD4 exome
AF:
AC:
5
AN:
1399156
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
690096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74438
GnomAD4 genome
AF:
AC:
6
AN:
152204
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.751T>G (p.L251V) alteration is located in exon 4 (coding exon 3) of the COL6A5 gene. This alteration results from a T to G substitution at nucleotide position 751, causing the leucine (L) at amino acid position 251 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Vest4
MutPred
Gain of helix (P = 0.132);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at